Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
May 16, 2019
| Rachel Schwartz
How Generic Drug Makers Are Responding to Price-Fixing Lawsuit
Video
May 14, 2019
| Erica Klinger
Take your safe, effective, affordable FDA-approved medicines with confidence.
Blog
May 13, 2019
| Erica Klinger
Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments
Press Release
May 13, 2019
| Rachel Schwartz
The 11th Annual Edition of AAM Access & Savings Report Finds Generic Savings Totaled $293 Billion in 2018
Press Release
May 12, 2019
| Rachel Schwartz
Response to 60 Minutes May 12, 2019: AAM Statement on the Importance of Competition to Promote Accessibility and Affordability of Medicines
Blog
May 9, 2019
| AAM
2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report
Press Release
May 8, 2019
| Rachel Schwartz
AAM Statement on Introduction of the Affordable Prescriptions for Patients Act
Press Release
May 7, 2019
| Jeff Francer
AAM Statement: Senate Judiciary Committee Hearing on Patents and Drug Prices
Infographic
May 6, 2019
| Erica Klinger
Anniversary of the May 10 Trade Amendments
Report
Apr 27, 2019
| Allen Goldberg
Commitment to Quality Excellence
Blog
Apr 25, 2019
| Allen Goldberg
National Drug Take Back Day Is Saturday: Here’s What You Need to Know
Press Release
Apr 24, 2019
| Jewel Smith
AAM Announces 2019 Associate Members
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action